NCT00061503已完成4 期
A Double-Masked, Placebo-Controlled, Paired Comparison Study of the Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The primary objective of this study is to describe the effect of TRAVATAN 0.004% Ophthalmic Solution on aqueous humor dynamics in subjects with a clinical diagnosis of open angle glaucoma (OAG) or ocular hypertension (OHT).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects 18 years of age or older
- •of either sex
- •of any race
- •diagnosed with ocular hypertension or open angle glaucoma
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Divided Dose of TRAVATAN®Ocular HypertensionOpen-angle GlaucomaNCT01298687Alcon Research67
已完成
4 期
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®GlaucomaOcular HypertensionNCT01664039Alcon Research104
已完成
4 期
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular HypertensionGlaucomaNCT00763061Alcon Research111
已完成
3 期
Travoprost 3-Month Safety and Efficacy StudyOcular HypertensionOpen-Angle GlaucomaNCT01453855Alcon Research1,099
已完成
3 期
Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR)Nonproliferative Diabetic RetinopathyNCT02718326Regeneron Pharmaceuticals402